HM-002-1005

· Hua Medicine Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM-002-1005, covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus [Phase 1]